RVMD Presents Clinical Data
Revolution Medicines to present clinical data from RAS(ON) inhibitor combination trials in pancreatic cancer at ESMO Gastrointestinal Cancers Congress 2026
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.